Thermo Fisher Scientific Advances Proteomics Through Select Collaborations and New Analytical Instrument Solutions

Thermo Fisher Scientific Advances Proteomics Through Select Collaborations and New Analytical Instrument Solutions The company will showcase their new chromatography and mass spectrometry solutions and collaborations at HUPO 2021 SAN JOSE, Calif., Nov. 15, 2021 /PRNewswire/ — HUPO — Thermo Fisher Scientific Inc., the world leader in serving science, today announced innovative proteomics solutions and... Read more

Brooks Automation Reports Results of Fourth Quarter of Fiscal 2021, Ended September 30, 2021, and Announces Quarterly Cash Dividend

Brooks Automation Reports Results of Fourth Quarter of Fiscal 2021, Ended September 30, 2021, and Announces Quarterly Cash Dividend Strong Double-Digit Growth Quarter Underscores Robust Demand Environment in Life Sciences CHELMSFORD, Mass., Nov. 10, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today reported financial results for the fiscal quarter ended September 30, 2021. Summary of... Read more

Brooks Automation Announces New Agreement With QTC Management, Inc. To Support The Military Reserve Health Readiness Program

Brooks Automation Announces New Agreement With QTC Management, Inc. To Support The Military Reserve Health Readiness Program CHELMSFORD, Mass., Nov. 8, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today announced that its newly branded Azenta Life Sciences business has been contracted by QTC Management, Inc., a Leidos company (NYSE: LDOS), to provide the storage and... Read more

Brooks Automation Announces Fiscal 2021 Fourth Quarter and Year-End Earnings Conference Call and Webcast

Brooks Automation Announces Fiscal 2021 Fourth Quarter and Year-End Earnings Conference Call and Webcast CHELMSFORD, Mass., Nov. 4, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2021 fourth quarter and year-end earnings which ended on September 30, 2021 on Wednesday, November 10, 2021 after the market closes. The Company will host a conference... Read more

BD Announces Fourth Fiscal Quarter And Full Year 2021 Results; Issues Fiscal Year 2022 Guidance

FRANKLIN LAKES, N.J., Nov. 4, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for the fourth fiscal quarter and full fiscal year ended September 30, 2021. “Our strong performance in fiscal 2021 was driven by the extraordinary efforts of our global team and demonstrates the resilience... Read more

Bruker Announces Major Advances in CCS-Enabled 4D Proteomics at ASMS

Bruker PaSER™ software now incorporates transformative CCS-enabled DIA-NN deep neural network learning with breakthrough dia-PASEF capabilities to identify: >8000 quantified cell lysate proteins with 40-minute gradients >5000 quantified cell lysate proteins with 4.8-minute separations on Evosep One >5000 quantified proteins in just 10 ng of cell lysate digest with 95-minute gradients Work-in-progress CCS-enabled ‘prm Live’... Read more

Thermo Fisher Scientific Reports Third Quarter 2021 Results

WALTHAM, Mass., Oct. 27, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended October 2, 2021. Third Quarter 2021 Highlights Third quarter revenue increased 9% to $9.33 billion. Third quarter GAAP diluted earnings per share (EPS) was $4.79. Third... Read more

Unchained Labs blasts Big Kahuna and Junior into the future, launches LEA 10!

October 19, 2021 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, released its LEA 10 automation software today – making Big Kahuna and Junior even more ready to plow through scientific challenges and workflow bottlenecks. Big Kahuna and Junior are workhorses that labs rely... Read more

Eppendorf AG completes conversion to European public limited company

19.10.2021 Hamburg, October 2021 • Conversion to SE (“Societas Europaea”) completed • No impact on current business• Group headquarter remains in Hamburg, Germany The internationally active life science company Eppendorf, headquartered in Hamburg, Germany, has completed its conversion to the European legal form Societas Europaea (SE) as of October 19, 2021. The company will operate as Eppendorf SE... Read more